<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Molecular biomarkers to determine the effectiveness of targeted therapies in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> treatment have been widely adopted in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), but those to predict chemotherapy sensitivity remain poorly defined </plain></SENT>
<SENT sid="1" pm="."><plain>We tested our hypothesis that KRAS mutation may be a predictor of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> sensitivity in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>KRAS was knocked-down in KRAS-mutant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells (DLD-1(G13D) and SW480(G12V)) by small interfering <z:chebi fb="40" ids="33697">RNAs</z:chebi> (siRNA) and overexpressed in KRAS-<z:mp ids='MP_0002169'>wild-type</z:mp> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells (COLO320DM) by KRAS-mutant vectors to generate paired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>These paired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells were tested by <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, irinotecan and 5FU to determine the change in drug sensitivity by <z:chebi fb="0" ids="53233">MTT</z:chebi> assay and flow cytometry </plain></SENT>
<SENT sid="4" pm="."><plain>Reasons for sensitivity alteration were further determined by western blot and real-time quantitative reverse transcriptase polymerase chain reaction (qRT -PCR) </plain></SENT>
<SENT sid="5" pm="."><plain>In KRAS-<z:mp ids='MP_0002169'>wild-type</z:mp> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells (COLO320DM), KRAS overexpression by mutant vectors caused excision repair cross-complementation group 1 (ERCC1) downregulation in protein and <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels, and enhanced <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> sensitivity </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, in KRAS-mutant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells (DLD-1(G13D) and SW480(G12V)), KRAS knocked-down by KRAS-siRNA led to ERCC1 upregulation and increased <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> resistance </plain></SENT>
<SENT sid="7" pm="."><plain>The sensitivity of irinotecan and 5FU had not changed in the paired <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain>To validate ERCC1 as a predictor of sensitivity for <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, ERCC1 was knocked-down by siRNA in KRAS-<z:mp ids='MP_0002169'>wild-type</z:mp> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, which restored <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> sensitivity </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast, ERCC1 was overexpressed by ERCC1-expressing vectors in KRAS-mutant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, and caused <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> resistance </plain></SENT>
<SENT sid="10" pm="."><plain>Overall, our findings suggest that KRAS mutation is a predictor of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> sensitivity in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells by the mechanism of ERCC1 downregulation </plain></SENT>
</text></document>